Raymond Wang
Director, Campbell Foundation Lysosomal Disorder Program,
University of California-Irvine
Raymond Wang, M.D. is the Director of the Foundation of Caring Lysosomal Storage Disorder Program at Children's Hospital of Orange County, a board certified clinical geneticist and biochemical genetics specialist. Dr. Wang's program provides:
Treatment for the lysosomal disorders that have existing therapies
Access to investigational treatment for patients with disorders that currently have no approved / effective therapy, and conducts
Translational research focused upon development of "next generation"treatments and cures for lysosomal storage disorder patients.
Dr. Wang attended Stanford University as an undergraduate, where he was a member of the Phi Beta Kappa honors society and graduated with a bachelor's degree with Honors and Distinction in Biological Sciences. He earned his medical degree from the University of California, Los Angeles (UCLA) where he was a member of the Alpha Omega Alpha honors society. He completed his internship and residency in medical genetics and pediatrics at Cedars-Sinai Medical Center where he served as chief resident in his final year of training. Dr. Wang completed his fellowship in biochemical genetics at the UCLA Intercampus Medical Genetics Program.
In 2006, Dr. Wang received the American College of Medical Genetics and Genzyme Fellowship in Biochemical Genetics Award. In the same year, he also received the Cedars-Sinai Medical Center's Paul Rubenstein Prize for Excellence in Resident Research.
Dr. Wang's clinical interests include: Pompe disease, Mucopolysaccharidosis, Neuronal Ceroid Lipofuscinoses, and neurodegenerative lysosomal storage diseases.
Dr. Wang's Research Focuses upon: gene therapy, clinical trial design and patient access for rare diseases, somatic genome editing, murine mouse models, treatment of orthopedic manifestations of MPS, and cardiovascular disease in lysosomal storage disorders.
Treatment for the lysosomal disorders that have existing therapies
Access to investigational treatment for patients with disorders that currently have no approved / effective therapy, and conducts
Translational research focused upon development of "next generation"treatments and cures for lysosomal storage disorder patients.
Dr. Wang attended Stanford University as an undergraduate, where he was a member of the Phi Beta Kappa honors society and graduated with a bachelor's degree with Honors and Distinction in Biological Sciences. He earned his medical degree from the University of California, Los Angeles (UCLA) where he was a member of the Alpha Omega Alpha honors society. He completed his internship and residency in medical genetics and pediatrics at Cedars-Sinai Medical Center where he served as chief resident in his final year of training. Dr. Wang completed his fellowship in biochemical genetics at the UCLA Intercampus Medical Genetics Program.
In 2006, Dr. Wang received the American College of Medical Genetics and Genzyme Fellowship in Biochemical Genetics Award. In the same year, he also received the Cedars-Sinai Medical Center's Paul Rubenstein Prize for Excellence in Resident Research.
Dr. Wang's clinical interests include: Pompe disease, Mucopolysaccharidosis, Neuronal Ceroid Lipofuscinoses, and neurodegenerative lysosomal storage diseases.
Dr. Wang's Research Focuses upon: gene therapy, clinical trial design and patient access for rare diseases, somatic genome editing, murine mouse models, treatment of orthopedic manifestations of MPS, and cardiovascular disease in lysosomal storage disorders.
)
)
){kind=logo}
){kind=logo}
){kind=logo}